CAG
IBB icon

Crestwood Advisors Group’s iShares Biotechnology ETF IBB Stock Holding History

Crestwood Advisors Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.62M Sell
13,751
-135
-1% -$23.2K 0.04% 216
2026
Q1 		$2.34M Sell
13,886
-325
-2% -$55.6K 0.04% 216
2025
Q4 		$2.4M Buy
14,211
+150
+1% +$24.4K 0.04% 203
2025
Q3 		$2.03M Sell
14,061
-358
-2% -$48.9K 0.03% 214
2025
Q2 		$1.82M Sell
14,419
-1,307
-8% -$160K 0.03% 218
2025
Q1 		$2.01M Sell
15,726
-1,142
-7% -$155K 0.04% 200
2024
Q4 		$2.23M Sell
16,868
-416
-2% -$58.5K 0.04% 180
2024
Q3 		$2.52M Sell
17,284
-615
-3% -$89K 0.05% 169
2024
Q2 		$2.46M Sell
17,899
-186
-1% -$24.8K 0.05% 160
2024
Q1 		$2.48M Sell
18,085
-983
-5% -$134K 0.05% 156
2023
Q4 		$2.59M Sell
19,068
-1,642
-8% -$200K 0.06% 150
2023
Q3 		$2.53M Sell
20,710
-1,721
-8% -$219K 0.07% 141
2023
Q2 		$2.85M Sell
22,431
-1,096
-5% -$142K 0.09% 101
2023
Q1 		$3.04M Sell
23,527
-1,040
-4% -$136K 0.1% 99
2022
Q4 		$3.23M Sell
24,567
-496
-2% -$64.1K 0.11% 98
2022
Q3 		$2.93M Sell
25,063
-14,246
-36% -$1.77M 0.1% 103
2022
Q2 		$4.62M Sell
39,309
-82,724
-68% -$9.82M 0.16% 92
2022
Q1 		$15.9M Sell
122,033
-3,788
-3% -$493K 0.45% 63
2021
Q4 		$19.2M Sell
125,821
-7,600
-6% -$1.18M 0.5% 58
2021
Q3 		$21.6M Buy
133,421
+507
+0.4% +$85.3K 0.61% 57
2021
Q2 		$21.8M Sell
132,914
-5,061
-4% -$780K 0.63% 56
2021
Q1 		$20.8M Sell
137,975
-88,117
-39% -$14M 0.65% 54
2020
Q4 		$34.3M Sell
226,092
-650
-0.3% -$92.9K 1.13% 34
2020
Q3 		$30.7M Buy
226,742
+5,402
+2% +$733K 1.15% 34
2020
Q2 		$30.3M Buy
221,340
+998
+0.5% +$127K 1.21% 29
2020
Q1 		$23.7M Sell
220,342
-6,116
-3% -$704K 1.18% 31
2019
Q4 		$27.3M Sell
226,458
-23,063
-9% -$2.57M 1.08% 37
2019
Q3 		$24.8M Buy
249,521
+230
+0.1% +$24.1K 1.09% 36
2019
Q2 		$27.2M Buy
249,291
+32,158
+15% +$3.42M 1.23% 28
2019
Q1 		$24.3M Buy
217,133
+10,390
+5% +$1.14M 1.74% 19
2018
Q4 		$19.9M Sell
206,743
-13,896
-6% -$1.47M 1.59% 23
2018
Q3 		$26.9M Sell
220,639
-341
-0.2% -$40.2K 1.89% 15
2018
Q2 		$25.8M Buy
220,980
+3,402
+2% +$364K 1.87% 15
2018
Q1 		$23.2M Buy
217,578
+3,629
+2% +$402K 1.82% 17
2017
Q4 		$22.8M Buy
213,949
+4,270
+2% +$456K 1.82% 18
2017
Q3 		$23.3M Buy
209,679
+3,321
+2% +$355K 2% 15
2017
Q2 		$22.1M Buy
206,358
+1,224
+0.6% +$121K 1.88% 17
2017
Q1 		$20.4M Buy
205,134
+17,157
+9% +$1.64M 1.8% 18
2016
Q4 		$16.6M Buy
187,977
+51,621
+38% +$4.7M 1.61% 25
2016
Q3 		$13.2M Buy
136,356
+15,924
+13% +$1.51M 1.57% 32
2016
Q2 		$10.3M Buy
+120,432
New +$10.8M 1.28% 37
2015
Q3 		– Sell
-1,680
Closed -$207K – 149
2015
Q2 		$207K Buy
+1,680
New +$201K 0.03% 145

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Crestwood Advisors Group's IBB Position: Q2 2026 in Review

Crestwood Advisors Group reduced its iShares Biotechnology ETF (IBB) stake by 0.97% in Q2 2026, selling an estimated $23.2K and leaving 13,751 shares worth $2.62M. The position accounts for 0.04% of the portfolio, ranked #216.

Crestwood Advisors Group first reported a position in IBB in Q2 2015 and has held it in 42 quarters since. The position peaked at $34.3M in Q4 2020. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Crestwood Advisors Group held 13,751 shares of iShares Biotechnology ETF worth $2.62M as of Q2 2026.
  • Crestwood Advisors Group sold 135 iShares Biotechnology ETF shares in Q2 2026, an estimated $23.2K.
  • iShares Biotechnology ETF made up 0.04% of Crestwood Advisors Group's portfolio in Q2 2026, its #216 holding.
  • Crestwood Advisors Group first reported a position in iShares Biotechnology ETF in Q2 2015 and has held it in 42 quarters since.
  • Crestwood Advisors Group's iShares Biotechnology ETF position peaked at $34.3M in Q4 2020.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Crestwood Advisors Group's 13F filing for Q2 2026, filed 3 Aug 2026.